Company News: King Pharmaceuticals

King Pharmaceuticals reported full-year revenue up 14% to $1.78 billion. Highlights of the year included the company's acquisition of Alpharma and winning US marketing approval for pain drug Embeda.

You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.